SCHIMMEL PAUL bought ATYR

October 9, 2025 · Form 4 insider transaction

SCHIMMEL PAUL bought 317,999 shares of aTyr Pharma, Inc. at $0.94 per share, a transaction worth $299.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
317,999
Price
$0.94
Total value
$299.4K
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 9, 2025
Filing dateOctober 9, 2025
Shares owned after1,413,023
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.93 to $0.95 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.; These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.

View the original Form 4 on SEC EDGAR